Product Information

KETAMINE 500 MG/10 ML VIAL is a generic product labeled by Hospira Inc., priced at $0.5397 per ML under NDC 00409205310. Its NADAC has been published 28 times since Dec 17, 2025.

The High Outlier badge above means this manufacturer's average price in the Ketamine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

KETAMINE 500 MG/10 ML VIAL

Ketamine Hydrochloride
$0.5397per ML
High Outlier
DEA Schedule CIII

Strength

50 mg/mL

Manufacturer

Hospira Inc.

NDC

00409205310

Classification

Generic

Dosage Form

INJECTION, SOLUTION, CONCENTRATE

Route

INTRAMUSCULAR; INTRAVENOUS

Last Updated

6/17/2026

Active Ingredients

KETAMINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA074549

On Market Since

11/30/2004

Pharmacological Classes

General Anesthesia
General Anesthetic

Price Statistics

The NADAC for KETAMINE 500 MG/10 ML VIAL has been published 28 times since Dec 17, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.5397 per ML
All-time high$0.5397 (Jun 24, 2026)
All-time low$0.5213 (Mar 18, 2026)
52-week high$0.5397
52-week low$0.5213
Median price$0.5315
Average price$0.5283
Largest weekly change+3.0% (Jun 17, 2026)
Weeks tracked28
Tracking sinceDec 17, 2025

Price History

1W

0.0%

1M

+3.0%

3M

+3.5%

6M

+1.2%

1Y

N/A

3Y

N/A

5Y

N/A

All

+1.2%

Generic Alternatives

The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of KETAMINE 500 MG/10 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for KETAMINE 500 MG/10 ML VIAL, manufactured by Hospira Inc., is $0.5397 per ML (NDC 00409205310), effective Jun 24, 2026.

How has the price of KETAMINE 500 MG/10 ML VIAL changed over time?

Over the history we have for it, the NADAC for KETAMINE 500 MG/10 ML VIAL has held within roughly two percent of its current level. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.

What are the highest and lowest recorded NADAC prices for KETAMINE 500 MG/10 ML VIAL?

Since Dec 17, 2025, the NADAC for KETAMINE 500 MG/10 ML VIAL has ranged from a low of $0.5213 (Mar 18, 2026) to a high of $0.5397 (Jun 24, 2026), with a median of $0.5315 per ML.

Are there cheaper alternatives to KETAMINE 500 MG/10 ML VIAL?

3 NADAC-published products share the same active ingredient, strength, and dosage form as KETAMINE 500 MG/10 ML VIAL, but none are currently priced below it.

Who manufactures KETAMINE 500 MG/10 ML VIAL?

KETAMINE 500 MG/10 ML VIAL (NDC 00409205310) is labeled by Hospira Inc., and CMS classifies it as a generic product.